Exploring the Potential for Therapeutic Lineage Reprogramming of Diabetes

Project Information

TheLiRep

Grant agreement ID: 641036

DOI 10.3030/641036

Project closed

EC signature date 11 March 2015

Start date 1 May 2015

End date 31 October 2016

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 150 000,00

EU contribution € 150 000,00

Coordinated by

MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)
Germany

Intellectual Property Rights

Patent (2)

Tgif2-induced reprogramming of hepatic cells to pancreatic progenitor cells and medical uses thereof

Application/Publication number: EP 14177287
Date: 2014-07-16
Applicant(s): MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)

TGIF2-INDUCED REPROGRAMMING OF HEPATIC CELLS TO PANCREATICPROGENITOR CELLS AND MEDICAL USES THEREOF

Application/Publication number: USPTO Application Nr. 14/800,880
Date: 2015-07-07
Applicant(s): MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)